Patent 10342875 was granted and assigned to Dow Pharmaceutical Sciences on July, 2019 by the United States Patent and Trademark Office.
The present invention provides compositions containing efinaconazole, butylated hydroxytoluene, a salt of ethylenediaminetetraacetic acid, and optional citric acid. The compositions exhibit stable color profiles and are useful in the treatment of fungal infections.